Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Gregory Arnsdorff, Nefertiti Greene, Brian Miller, Rick Brajer, Stephen Stamp

Premium

AdvaMedDx, a division of the Advanced Medical Technology Association, announced the election of several new members to its board of directors. The new board members are: Gregory Arnsdorff, VP of Abbott Laboratories and president of Abbott Point of Care; Nefertiti Greene, VP of US diabetes care at Bayer HealthCare Diabetes Care; Brian Miller, managing partner at Linden Capital Partners; and Rick Brajer, president and CEO of LipoScience.


AssureRx Health has appointed Stephen Stamp as its senior VP and CFO and Jeffrey Bush as if VP of payor markets and reimbursement. Stamp comes to AssureRx from EZCorp, where he was CFO. Bush joins AssureRx from Becton, Dickinson and Company, where he served as senior director of reimbursement strategy and payment policy.

According to the AssureRx, the new appointments come as demand for its GeneSight pharmacogenomic testing service is increasing.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.